- Lobbying
- Dylan AND Moore
Lobbying Arrangements Results for 'Dylan Moore'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Issues related to remote therapeutic monitoring; work on HR 5394 |
PatchRx
|
Farragut Partners LLP | |||
Details Work related to passage of the FDA Modernization Act of 2021 (S. 2952) (H.R. 2565) |
Animal Wellness Action
|
Farragut Partners LLP | |||
Details General healthcare issues and competition issues |
Illumina
|
Farragut Partners LLP | |||
Details Issues related to medication adherence and population health. |
PatientPoint
|
Farragut Partners LLP | |||
Details Issues related to the organ donation system and the organ procurement transplantation network. |
Organize Action Network
|
Farragut Partners LLP | |||
Details Issues related to the production of US based manufacturing of medical grade face masks |
Sanctuary Systems
|
Farragut Partners LLP | |||
Details Issues related to coverage policy for Medicare reimbursement of breast reconstruction surgery |
Elisabeth Potter MD PLLC
|
Farragut Partners LLP | |||
Details Issues related to the organ donation system and the organ procurement transplantation network. |
Organize
Patient Advocacy Network |
Farragut Partners LLP | |||
Details General Healthcare issues, drug pricing legislation and issues related to chemotherapy Induced Neutropenia |
BeyondSpring Inc.
|
Farragut Partners LLP | |||
Details General representation. Regulations and legislation relating to PBMs and drug pricing. Issues related to the 340B drug discount program |
Pharmaceutical Research and Manufacturers of America
|
Farragut Partners LLP | |||
Details Issues relating to the implementation Surprise Medical Billing |
CMT Solutions
|
Farragut Partners LLP | |||
Details Issues related to trade and tax policy related to duty drawbacks |
Charter Brokerage
|
Farragut Partners LLP | |||
Details Issues related to Medicare coverage for blood glucose monitoring |
Intuity Medical
|
Farragut Partners LLP | |||
Details Issues related to broadband infrastructure, grant/subsidy programs, privacy and telecom regulation. |
Connect Holding LLC
|
Farragut Partners LLP | |||
Details Issues pertaining to data security and privacy |
21st Century Privacy Coalition
|
Farragut Partners LLP | |||
Details Issues related to coverage policies and pbms, general healthcare issues |
Assertio Holdings, Inc
|
Farragut Partners LLP | |||
Details Issues pertaining to healthcare. |
American Independent Medical Practice Association
|
Farragut Partners LLP | |||
Details Issues relating to the coverage of treatments for iron deficiency anemia. |
AMAG Pharmaceuticals, Inc.
|
Farragut Partners LLP | |||
Details Issues related to exon 20 cancer mutation. Issues related to FDA remote foreign site inspections |
Spectrum Pharmaceuticals, Inc
|
Farragut Partners LLP | |||
Details Issues relating to the coverage of treatments for iron deficiency anemia |
Daiichi Sankyo Inc
|
Farragut Partners LLP | |||
Details general representation related to the power grid, energy efficiency and climate change |
DTE Energy
|
Farragut Partners LLP | |||
Details Issues related to coverage of peripheral nerve stimulation |
SPR Therapeutics
|
Farragut Partners LLP | |||
Details Issues Related to a COVID-19 Vaccine. Monitoring Vaccine legislation. Drug pricing. |
Novavax, Inc.
|
Farragut Partners LLP | |||
Details Issues related to user fee reauthorization. Legislative efforts related to the FIND Act (H.R.4479) (S.2609) |
Lantheus Medical Imaging, Inc.
|
Farragut Partners LLP | |||
Details Issues related to secure modifications act, ports and vaccines. Issues related to clean water |
NantWorks
|
Farragut Partners LLP | |||
Details Coverage and reimbursement policy for medical devices/THV Medicare coverage of breakthrough therapies Policies promoting medical innovation. Coverage with evidence development. 21st Century Cures 2.0 |
Edwards Lifesciences, LLC
|
Farragut Partners LLP | |||
Details Issues related to OB/GYN healthcare providers. Issues relating to alternative payment models. Issues relating to maternal health |
U.S. Women's Health Alliance
|
Farragut Partners LLP | |||
Details Issues affecting the regulation of greenhouse gas emissions from power plants and other air and solid waste issues affecting power plant operations. Issues affecting federal regulation of electrici... |
Southern Company
|
Farragut Partners LLP | |||
Details Coverage and reimbursement policy for HCV and HIV portfolios. Issues pertaining to the six protected classes. Drug pricing legislation- part D redesign. Issues related to Medicaid drug rebate progr... |
Gilead Sciences Inc.
|
Farragut Partners LLP | |||
Details Issues pertaining to Medicare reimbursement. Issues pertaining to drug shortages, legislation regarding the 340B Drug discount program. Issues pertaining to sequestration; Issues related to pharmac... |
OneOncology Inc.
|
Farragut Partners LLP | |||
Details Monitoring electrification issues in Congress |
Omega Flex
|
Farragut Partners LLP | |||
Details Issues pertaining to Medicare reimbursement. Issues pertaining to Medicare coverage decisions. Issues related to ambulatory surgery centers. Opioid and prescription drug monitoring programs. U.S. S... |
American Society of Interventional Pain Physicians
|
Farragut Partners LLP | |||
Details Net Neutrality. Spectrum Reform. Cyber security. Program carriage. Rural Broadband Infrastructure. Privacy Issues Privacy issues relating to the gathering, retention, and use of online information. |
Comcast Corporation
|
Farragut Partners LLP | |||
Details Consumer protection and legislation related to the primary ticketing market Issues related to tax provisions in COVID-19 stimulus legislation Monitoring competition legislation |
Live Nation Entertainment
|
Farragut Partners LLP | |||
Details Legislation related to rewriting the Telecommunications act of 1934. Privacy issues Legislation related to autonomous issues and legislation related to automotive safety |
Cox Enterprises, Inc
|
Farragut Partners LLP | |||
Details Issues related to the 340B drug discount program. Medicare Part B. Biosimilar Legislation. Drug pricing legislation. Issues related to ASP reporting. Issues related to patient safety in attorney ad... |
Johnson & Johnson Services, Inc.
|
Farragut Partners LLP | |||
Details Issues regarding Medicare payment policies for Part B drugs. Issues related to the 340B Drug discount program. Drug Pricing Proposals. CMMI Guardrails. Issues related to drug pricing (IPI, Part B r... |
Genentech
|
Farragut Partners LLP | |||
Details lobbying activities specific to wireless policy on consumer protection and privacy issues in the House and Senate Commerce and Judiciary Committees; general lobbying spectrum related issues, includ... |
T-Mobile Association
|
Farragut Partners LLP | |||
Details Issues related to non-opioid alternatives reimbursement. Coverage decisions related to anti nausea treatments. Federal non-opioid directive legislation |
Heron Therapeutics, Inc.
|
Farragut Partners LLP | |||
Details Issues pertaining to Medicare reimbursement. Legislation regarding the 340B Drug discount program. Issues pertaining to sequestration; Issues related to pharmacy benefit managers. Drug Pricing legi... |
Community Oncology Alliance
|
Farragut Partners LLP | |||
Details Privacy and Behavioral Advertising issues relating to the gathering, retention, and use of online information. Program access, Net neutrality, spectrum reform and reallocation, broadband deployment... |
National Cable and Telecommunications Association
|
Farragut Partners LLP | |||
Details General Representation related to telecommunications legislation and regulation. Privacy issues relating to the gathering, retention, and use of online information. General Representation related t... |
DIRECTV
|
Farragut Partners LLP | |||
Details "Waters of the US" WOTUS Air Quality Standards Carbon Capture, Utilization and Storage (CCUS) CWA Section 404 Nationwide Permits GHG Regulations for Stationary Sources NEPA Modernization Strengthen... |
National Association of Manufacturers
|
in-house lobbying | |||
Details S.Con.Res.2 - A concurrent resolution commending the bravery, courage, and resolve of the women and men of Iran demonstrating in more than 133 cities and risking their safety to speak out against t... |
J Street
|
in-house lobbying |